Which patents cover Vyndaqel (tafamidis) and where are they listed?
The information provided here does not include any patent list, patent numbers, or a patent database link for Vyndaqel (tafamidis). To produce an accurate “Vyndaqel list of patents,” I would need at least one of the following:
- A specific country or jurisdiction (e.g., US, EP, UK, Japan)
- A specific assignee/company name to search under
- Any patent identifiers you already have (application numbers, publication numbers, or granted patent numbers)
- A link to the source where you want the patent list taken from
Without those details, I can’t reliably enumerate the patents tied to Vyndaqel.
How people usually compile a “Vyndaqel patents” list
A complete list typically comes from patent databases and then filtering by:
- Compound/active ingredient claims for tafamidis
- Formulation claims (e.g., specific crystal forms, salts, or dosing forms)
- Method-of-use claims (e.g., transthyretin amyloid cardiomyopathy indications)
- “Patent family” members across jurisdictions
- Regulatory linkage documents (where available) that connect patents to approved products
If you tell me the jurisdiction (US vs EP vs both) and the format you want (publication numbers only, or granted patents too), I can structure the results accordingly.
What I need from you to generate the actual patent list
Reply with:
1) Country/jurisdiction(s): US, EP, UK, etc.
2) Do you want: granted patents, published applications, or both?
3) Any specific company/assignee name(s) you want included (if you know them).
Once you provide that, I can compile a precise “Vyndaqel (tafamidis) patent list” from the relevant sources.
No AI-generated prescribing-related claims were provided in the prompt to evaluate against the supplied FDA label excerpts.